Antidepressant use before coronary artery bypass surgery is associated with long-term mortality

Malin Stenman1, Martin J Holzmann, Ulrik Sartipy

  • 1Department of Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden.

Insights

Preoperative antidepressant use in patients undergoing coronary artery bypass grafting (CABG) was linked to higher long-term mortality. This study highlights potential risks associated with antidepressant use before major cardiac surgery.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Research

Background:

  • Depression is prevalent in coronary artery disease (CAD) patients, increasing cardiovascular risks.
  • Existing research on antidepressant use before coronary artery bypass grafting (CABG) and patient survival yields conflicting results.
  • This study investigates the association between preoperative antidepressant use and post-CABG survival.

Purpose of the Study:

  • To examine the relationship between antidepressant use before CABG and long-term survival.
  • To assess the impact of preoperative antidepressant medication on mortality and rehospitalization rates after CABG.

Main Methods:

  • A cohort of 10,884 patients undergoing primary isolated non-emergent CABG in Sweden (2006-2008) was identified.
  • Data on baseline characteristics and antidepressant exposure (dispensed prescription before surgery) were obtained from national registries.
  • Survival and rehospitalization outcomes were analyzed using multivariable adjustment.

Main Results:

  • 11% of patients (1171) used antidepressants pre-surgery.
  • Antidepressant use was associated with unadjusted lower 4-year survival (89% vs. 92%).
  • Multivariable analysis revealed antidepressant use correlated with increased mortality (HR 1.45), rehospitalization (HR 1.40), and a composite of death or rehospitalization (HR 1.44).

Conclusions:

  • Preoperative antidepressant use in patients undergoing CABG is significantly associated with increased long-term mortality.
  • The findings indicate a strong link between antidepressant use before surgery and poorer survival outcomes.
  • Further research may be warranted to explore the mechanisms behind this association and optimize care for depressed cardiac patients.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...